Dexcom has received a warning letter from the FDA, after the agency uncovered issues during two inspections of the continuous glucose monitor maker’s facilities last year. In a filing with the SEC, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback